This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Optineurin.
Mechanistically, recruits TBK1 in the Golgi apparatus, boosting its trans-phosphorylation after RLR or TLR3 stimulation (PubMed:27538435). In turn, triggered TBK1 phosphorylates its downstream partner IRF3 to generate IFN-beta.
Human | |
---|---|
Gene Name: | OPTN |
Uniprot: | Q96CV9 |
Entrez: | 10133 |
Belongs to: |
---|
No superfamily |
FIP2FIP-2; GLC1Eglaucoma 1, open angle, E (adult-onset); HIP7ALS12; Huntingtin interacting protein L; Huntingtin yeast partner L; Huntingtin-interacting protein 7; Huntingtin-interacting protein L; HYPLHIP-7; NEMO-related protein; NRPE3-14.7K-interacting protein; Optic neuropathy-inducing protein; optineurin; TFIIIA-INTP; Transcription factor IIIA-interacting protein; transcrption factor IIIA-interacting protein; tumor necrosis factor alpha-inducible cellular protein containing leucinezipper domains
Mass (kDA):
65.922 kDA
Human | |
---|---|
Location: | 10p13 |
Sequence: | 10; NC_000010.11 (13100082..13138308) |
Present in aqueous humor of the eye (at protein level). Highly expressed in trabecular meshwork. Expressed nonpigmented ciliary epithelium, retina, brain, adrenal cortex, fetus, lymphocyte, fibroblast, skeletal muscle, heart, liver, brain and placenta.
Cytoplasm, perinuclear region. Golgi apparatus. Golgi apparatus, trans-Golgi network. Cytoplasmic vesicle, autophagosome. Cytoplasmic vesicle. Recycling endosome. Found in the perinuclear region and associates with the Golgi apparatus (PubMed:27534431). Colocalizes with MYO6 and RAB8 at the Golgi complex and in vesicular structures close to the plasma membrane. Localizes to LC3-positive cytoplasmic vesicles upon induction of autophagy.
PMID: 9488477 by Li Y., et al. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.
PMID: 11834836 by Rezaie T., et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin.